Durably improving health is really, really hard. I’ve discussed this in the context of drug discovery, which must contend with the every-more-apparent reality that biology is incredibly complex, and science remarkably fragile. I’ve discussed this in the context of patient behavior, focusing on the need...
Thu, Apr 5 2012
Filed under: Filed under: Uncategorized, health, Health care, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Atul Gawande, Peter Pronovost, Patient, Hospital, Patient Protection and Affordable Care Act, New England Journal of Medicine, TechCrunch, Building the Organization of Tomorrow